Song et al. showed that ATOH8 is frequently downregulated in HCC and can inhibit the stem cell features of HCC via repressing the transcription of OCT4, NANOG, and CD133 and sensitizing cells to chemotherapy [2]. This evidence concerns the gene ATOH8 and hepatocellular carcinoma.